BOESS CARSTEN has filed 14 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 20000 shares of Atrium Therapeutics, Inc. ($RNA) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Atrium Therapeutics, Inc. | $RNA | BOESS CARSTEN | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 10034 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Common Stock | 6692 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.00% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 13489 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Not found | D | Stock Option (Right to Buy) | 20858 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.01% |
| June 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | BOESS CARSTEN | Not found | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 94,807,773 | 9999.99% | 0.03% |
| June 10, 2025 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Director | A | Common Stock | 6692 | $0.00 | 6,692.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 10, 2025 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 10034 | $0.00 | 10,034.0000 | 120,212,301 | 9999.99% | 0.01% |
| June 13, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | BOESS CARSTEN | Not found | A | Stock Option (Right to Buy) | 23944 | $0.00 | 23,944.0000 | 84,009,004 | 9999.99% | 0.03% |
| June 13, 2024 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 13489 | $0.00 | 13,489.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Avidity Biosciences, Inc. | $RNAM | BOESS CARSTEN | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |